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ABSTRACT 
 
MODELING THE PSYCHIATRIC ASPECTS OF POLYCYSTIC OVARY 
SYNDROME AND INDUCED STRESS 
by 
Danielle Leigh Peecher 
May 2018 
 
Polycystic ovary syndrome (PCOS) is an endocrine disorder in women that is 
characterized by excess testosterone and is associated with increased risk of infertility.  
Women with PCOS also show higher rates of depression and anxiety.  Modeling PCOS in 
mice via administration of dihydrotestosterone (DHT) results in physiological alterations 
that are consistent with the physiological symptoms of PCOS in women. While some 
studies have investigated behavioral changes in PCOS mouse models, findings have 
varied.  Thus, the current research examined whether a PCOS model with an additional 
stress factor resulted in behavioral changes.  To create a stress condition, subjects were 
implanted with corticosterone (CORT) pellets to model the complex interaction of stress 
and PCOS on depression- and anxiety-like behavior.  Data analysis for depression-like 
behavior on the forced swim test showed a significant main effect of time, with subjects 
spending more time immobile across the 5-minute test, F(4, 108) = 104.43, ps < .001.  
Anxiety-like behavior on the elevated zero maze showed a significant time x prenatal 
treatment interaction, F(4, 108) = 2.71, p = .034. The hypothesis that the prenatal PCOS 
model in conjunction with the stress condition would better model the human condition 
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and result in behavioral alterations was only partially supported. These findings are an 
important step toward understanding the intersection of stress, mental health, and PCOS 
for the approximately five million women in the United States with this disorder. 
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CHAPTER I 
 
INTRODUCTION 
 
 Of endocrine disorders in reproductive-aged women, polycystic ovary syndrome 
(PCOS) is the most often diagnosed (Yu, Hao, Wang, Shen, & Kang, 2016). PCOS is a 
disorder associated with metabolic, reproductive, and hormonal changes.  Many negative 
health outcomes have been associated with PCOS, including infertility, obesity, insulin 
resistance, and an increased risk of diabetes (Ressler, Grayson, Ulrick-Lai, & Seeley, 
2015).  Other common symptoms of PCOS include irregular menstrual cycles, increased 
levels of the hormone testosterone, and ovarian cysts (as cited in Yu et al., 2016). As will 
be discussed in depth in the follow sections, PCOS in women is often associated with 
higher than normal rates of psychiatric illness.  As a result, understanding the connection 
between PCOS as a biological disorder and its psychological components is crucial.  The 
etiology for women with PCOS developing psychological disorders is currently unclear.  
Research on how anxiety, depression, and other mental disruptions are related to PCOS is 
important for both medical and psychological fields (Rassi et al., 2010).   
The purpose of the current research was to induce a prenatal model of PCOS in 
rodents to understand the physiology and psychiatric components of the disorder. In 
addition, a factor of stress was added to attempt to better model the human condition and 
understand the complexities of PCOS. The hypothesis that androgen elevation would 
produce significant anxiety-like and depression-like behaviors, as measured with mouse 
models for anxiety and depression, was examined. Utilizing behavioral models for 
anxiety and depression with the prenatal mouse model—we hoped to identify possible 
effects of PCOS and androgen elevation in offspring. Overall, answering questions 
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related to PCOS and the development of psychiatric illness is necessary for treatment and 
better understanding of the disorder.  
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CHAPTER II 
LITERATURE REVIEW 
Physiology of PCOS 
Hyperandrogenism is a medical condition that creates excess testosterone 
hormone in females and is a factor in PCOS. Increased testosterone is also related to 
ovarian and reproductive disruptions (Rasgon et al., 2005). Testosterone is predominately 
associated with masculinity and high testosterone in women tends to increase facial hair, 
aggression, muscle mass, and general masculine features. Hahn and colleagues (2005) 
studied a sample of 120 women with PCOS and a demographic-matched control group 
and found those with PCOS had significantly higher levels of serum testosterone.  
Another study, using a hormone assay, again found increased total testosterone levels in 
PCOS women (Barth, Field, Yasmin, & Balen, 2010). Amiri and colleagues (2014) 
examined metformin and flutamide in treating PCOS and measured testosterone levels 
along with hirsutism scores (i.e., abnormal hair growth and facial hair) that appeared to 
correlate with increased testosterone. Therefore, hyperandrogenism functions in PCOS by 
increasing testosterone levels, which may associate with decreased fertility and 
manifestations of masculine characteristics or behaviors. 
An example of reproductive disruptions includes the increased risk of infertility in 
women with PCOS. According to a PCOS review article, infertility often results from the 
lack of ovulation (i.e., anovulation) in respective women (Goodarzi, Dumensic, 
Chazenbalk, & Azziz, 2011).  An important longitudinal cohort study examined self-
reports on infertility, infertility hormone treatments, and regularity of ovulation in women 
with and without PCOS (Joham, Teede, Ranasinha, Zoungas, & Boyle, 2015).  According 
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to participants’ reports, 72% and 16% of women with PCOS and without, respectively, 
experienced infertility. Infertility rates were significantly higher in women with PCOS; 
however, Joham and colleagues (2015) discussed the limitation that these infertility rates 
only come from women who have attempted pregnancy, which may underestimate actual 
infertility rates.  As proposed by Tian, Shen, Lu, Norman, and Wang (2007), infertility in 
women with PCOS also interacts with insulin resistance as supported by their findings of 
a 30.8% risk for spontaneous abortion in women with PCOS and a 47.8% for those only 
with insulin resistance. Described by Tian et al., insulin resistance is predicted to mediate 
the relationship of obesity, PCOS, and spontaneous abortion. More specifically, both 
obese women and women with PCOS are at risk for insulin resistance.  Women with 
PCOS have higher levels of obesity and, thus, these factors contribute to difficulty in 
achieving or maintaining a pregnancy.  
Beyond infertility, insulin resistance also increases the risk of diabetes in women 
with PCOS. Although the exact prevalence of Type 2 diabetes in women with and 
without PCOS varies across studies (Moran, Misso, Wild, & Norman, 2010), Talbott et al. 
(2007) documented that 12.8% of women with PCOS had Type 2 diabetes, significantly 
more than the 3.6% of women without PCOS. Importantly, in a review by Ressler et al. 
(2015), obesity was reported to be prevalent in PCOS populations with rates ranging 
between 61 to 76% of those in diagnosed samples (Ching, Burke, & Stuckey, 2007; 
Glueck et al., 2005).  Animal research indicates that obesity can intensify PCOS 
symptomology with rats fed a high fat diet having higher insulin resistance compared to 
rats on a low fat diet (Ressler et al., 2015). Unfortunately, higher insulin resistance may 
be an inescapable symptom of PCOS because rats modeling PCOS that were fed a low fat 
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diet still exhibited insulin resistance, just to a lesser extent than did rats modeling PCOS 
that were fed a high fat diet. As these researchers concluded, dietary changes may not be 
effective in improving insulin resistance in women with PCOS.  
PCOS is a heterogeneous condition and, therefore, it has been difficult for 
clinicians and researchers to understand all of its associated metabolic, reproductive, and 
hormonal changes, making consistent diagnostic criteria difficult to establish. For 
example, March et al. (2010) utilized three possible PCOS criteria, from the National 
Institutes of Health (NIH), the Rotterdam, and the Androgen Excess Society (AES), to 
determine which produced a higher estimate of the prevalence of the disease.  The results 
yielded prevalence rates of PCOS ranging from 8.7% to 11.9% using NIH and AES 
criteria, respectively. The Rotterdam criteria provided a prevalence rate of 10.2% (March 
et al., 2010). More research on PCOS is clearly needed to improve diagnostic criteria as 
well as to enhance research on treatment options.  
PCOS and Psychiatric Disorders 
 Often mental illness is dually diagnosed with other health concerns. For example, 
depression is often associated with other mental health disorders or medical conditions, 
and PCOS’s wide variety of symptoms includes psychiatric disturbances (e.g., Yu et al., 
2016). Determining how anxiety, depression, and other potential psychological, 
behavioral, or cognitive changes are related to PCOS is important for both medical and 
psychological fields (Rassi et al., 2010).  Rassi and colleagues (2010) found that 55.9% 
of sampled women with PCOS were also diagnosed with a psychiatric disorder. The most 
commonly diagnosed disorders in that sample were depression (26.4%) and anxiety 
(9.7%). Jedel and colleagues (2010) used a small sample of 60 women, 30 of whom were 
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diagnosed with PCOS and found self-reported anxiety on the Brief Scale for Anxiety to 
be significantly higher in the PCOS group.  Another study found that depression, as 
measured by a psychiatrist, had a 2.93% higher prevalence in women with PCOS 
compared to controls (Hung et al., 2014).  Thus, the research indicates that women with 
PCOS are more likely to exhibit depression or other mood disorders, but the etiology of 
psychiatric disorders in PCOS remains unclear. 
Investigating the connection between PCOS and depression, Yu et al. (2016) 
measured depressive-like behaviors and changes in monoamines (i.e., serotonin, 
dopamine, norepinephrine) in a PCOS mouse model that used androgen treatment to 
induce PCOS-like symptoms and found significantly higher levels of serotonin in the 
hippocampus, striatum, hypothalamus, and dorsal ralph nucleus brain regions in treated 
mice compared to controls.  Accordingly, it is possible that depression and other 
psychological disorders develop in PCOS due to androgen excess and subsequent 
biochemical changes in the brain. 
Thus, while the hyperandrogenism associated with PCOS may underlie both the 
physical and psychological symptoms of the disorder, another potential pathway in the 
etiology of psychological disorders in women with PCOS may be that coping with the 
physical symptoms of PCOS, such as infertility and obesity, leads to psychological 
disorders such as anxiety and depression.  Supporting such a possibility is research by 
Annagur et al. (2013) who reported that testosterone levels were not significantly 
different in those with or without depression and PCOS.  Cwikel, Gidron, and Sheiner 
(2004) suggested that stressors associated with infertility manifest as depression or 
anxiety in women with PCOS, and Hahn et al. (2005) found that women with PCOS 
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reported decreased quality of life in physical, emotional, social, and psychological areas. 
In contrast, a meta-analysis of research on depression and PCOS found that, although 
there was an increased risk of depression in women with PCOS, that risk was 
independent of obesity (Dorkas, Clifton, Futterweit, & Wild, 2011). Regardless of the 
mechanism of action, PCOS is clearly interconnected with mood disturbances and, 
ultimately, affects the quality of life for those living with the disease. However, 
understanding the mechanism of action and how the physical symptoms of PCOS are 
related to psychological disorders is crucial in developing and investigating potential 
treatments for anxiety and depression in women with PCOS.  
Stress, Psychological Disorders, and PCOS  
In attempting to explain the relationship between PCOS and depression, Benson 
et al. (2009) suggested that stress response differences in women with PCOS might 
contribute to the observed increased rates of depression among patients. In that study, 
women with PCOS had significantly increased heart rate and cortisol levels when stress 
was induced via a public speaking task. It remains important to understand this 
interconnection between stress, physiological changes, and mental health.    
Many risks factors and processes of chronic stress are related to and intertwined 
with the etiology of mental illness.  It is accepted among mental health and biological 
fields that depression is caused by a combination of biopsychosocial factors (e.g., Dinan, 
1994; Duman, Aghajanian, Sanacora, & Krystal, 2016; Menke & Binder, 2014; Nester, 
2014).  For example, studies in epigenetics identify genetic risk factors for depression 
being ‘turned-on’ in reaction to stress (Nester, 2014) potentially through the actions of 
the glucocorticoid stress hormones, cortisol in humans and corticosterone in rodents. 
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Cortisol is involved in acute and chronic stress responses and is the end product of the 
hypothalamic-pituitary-adrenal (HPA) axis, which responds to physiological and 
psychological stressors with increased plasma cortisol levels (Varghese & Brown, 2001). 
Physiological effects of cortisol include altering “…basal processes such as fat and 
glucose, metabolism, blood pressure, inflammatory, and immune responses…” (as cited 
in Staufenbiel et al., 2013, p. 1221). While sympathetic arousal reallocates immediate 
energy resources to systems designed to enhance survival during stress (i.e., fight-or-
flight), cortisol continues the reallocation of energy away from non-crucial body 
functions during longer acute stressors or under chronic stress (Boersma & Tamashiro, 
2015). Importantly, elevated cortisol levels are part of an inhibitory feedback loop in 
which cortisol crosses the blood-brain barrier, binds to glucocorticoid receptors in the 
hypothalamus, and inhibits further HPA activity, bringing the stress response to an end 
and restoring homeostasis. 
Notably, cortisol may play a role in some psychological disorders.  For example, 
neuroendocrine studies have identified a relationship between decreased serotonin and 
increased cortisol in some cases of depression (Dinan, 1994).  Graeff, Guimaraes, De 
Andrade, and Deakin (1996) report that by targeting serotonin receptors (i.e., 
pharmaceutically) they were able to increase public speaking anxiety in humans as well 
as anxiety-like behaviors in mice. Thus, Graeff et al. reduced serotonin using antagonist 
drugs and, subsequently, may have increased cortisol.  Dinan (1994) reviewed the 
complexities of increased levels of cortisol binding to glucocorticoid receptors in limbic, 
hippocampal, and hypothalamic brain regions; and concluded, “If this hypothesis is 
correct … these abnormalities in central monoamines are primary and induce secondary 
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endocrine disturbance” (Dinan, 1994, p. 369). As described, glucocorticoid receptors in 
these regions (i.e., limbic, hippocampal, and hypothalamic) link cortisol to monoamine 
changes and, possibly, psychological disorders.  Connections between cortisol, HPA 
dysfunction, and depression have been demonstrated by the dexamethasone suppression 
test (Carroll, 1982). Dexamethasone is a synthetic cortisol that crosses the blood-brain 
barrier and should reduce endogenous cortisol levels via inhibition of further HPA 
activity. However, in a proportion of individuals with depression, cortisol levels remain 
elevated following dexamethasone administration, suggesting neuroendocrine 
dysfunction in depression. 
HPA and Hypothalamic-Pituitary-Gonadal (HPG) Interactions   
Cortisol release from the adrenal gland in response to stress reallocates energy to 
prepare for physical exertion, and part of that process alters HPG axis activity. Reviewing 
the connection between the HPA and HPG axis, Whirledge and Cidlowski (2010) 
describe three contributions of the HPA axis onto the HPG system. First off, the 
hypothalamus, when stimulated by excess cortisol, decreases production of gonadotropin-
releasing hormone (GnRH), which is an initial step in HPG activation. Secondly, 
Whirledge and Cidlowski reported that the pituitary gland can inhibit secretion of 
luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which together are 
responsible for ovulation and reproductive processes. The third interaction is the gonadal 
aspect and decreased formation of proper hormones and gamete production (i.e., estrogen 
and oocytes). Divyashree and Yajurvedi (2016) reviewed the impact of stress-induced 
HPA activity on HPG function, finding significant increases in adrenal gland weight and 
serum cortisol concentrations associated with decreased estrous cycles and decreased 
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ovary weight following exposure to eight weeks of stress in rats. Thus, reductions in 
gonadal functions have been documented in response to chronic stress, and such 
pathways may contribute to exacerbation of HPG disruptions in PCOS, given the 
psychological and physiological stress associated with infertility and anovulation.  
PCOS and Stress.  Considering the marked effects on androgen hormone levels, 
reproductive functions, and metabolic systems in PCOS, it may be possible to draw 
connections between HPG alterations and stress systems.  Supporting the connection 
between stress and PCOS, Ressler et al. (2015) measured HPA activation in a mouse 
model of PCOS by a novel environment stressor.  Surprisingly, Ressler et al. found that, 
in novel environment tests, PCOS mice had lower corticosterone responses than did 
controls. However, these mice also demonstrated anxiety-like behavior in an elevated 
plus maze; a behavioral finding that would typically correlate with increased 
corticosterone levels.  Measuring corticosterone levels in animal models becomes 
important when attempting to parse out these discrepancies. These results point to 
possible differences between PCOS and controls in processing or responding to stressful 
events.    
Unfortunately, as previously noted, variations of physical symptoms in women 
with PCOS have made it difficult for researchers to identify a common etiology (Abbott, 
Tarantal, & Dumesic, 2009). Additionally, psychological symptoms such as anxiety and 
depression may stem from underlying physiological differences in HPA and/or HPG 
systems in women suffering from the disorder or from stressors caused by PCOS 
symptomology (i.e., infertility). Fortunately, animal models of PCOS may allow 
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researchers to disentangle the potential causes of psychological disorders associated with 
PCOS.  
 
Animal Models 
Biological Models. Animal models, especially in rodents, are widely used in 
PCOS research and, while these models all involve androgen administration, they vary in 
the timing of that androgen exposure.  PCOS models either involve prenatal or 
peri/postnatal androgen administration.  Thus, prenatal and postnatal PCOS models target 
differences in organizational and activational processes in the HPG system, respectively 
(Foecking, McDevitt, Acosta-Martinez, & Horton, 2008). For example, androgens can 
play an organizational or activational role in “masculinization and defeminization of the 
neuroanatomy, behavior, and endocrinology of male rats” (as cited in Foecking et al., 
2008, p. 3). Prenatal models focus on the hypothesis that PCOS, although diagnosed in 
women post-puberty, is actually due to differences in hormonal systems that were 
organized and established during prenatal development. Roland, Nunemaker, Keller, and 
Moenter (2010) state that dysfunction of reproduction in prenatally androgenized (PNA) 
mice relates to “…androgen programming of the reproductive axis…” (p. 221).  
Therefore, prenatal models alter pathology earlier in development than do postnatal 
models, changing the organization structure of pathways that will then be activated in 
puberty. 
Only one study to date directly compares the effects of prenatal and postnatal 
mouse PCOS models involving androgen administration and focuses on physiological 
phenotypes, including ovarian weights and cycles, insulin resistance, and adipose tissue 
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changes (Caldwell et al., 2014).  Caldwell and colleagues (2014) found that mice in a 
postnatal PCOS model underwent fewer estrous cycles in two weeks than did those in a 
prenatal PCOS model.  In contrast, mice in a prenatal PCOS model exhibited a higher 
percentage of unhealthy ovarian follicle cells than did those in a postnatal PCOS model. 
Thus, either postnatal or prenatal models can be utilized when modeling PCOS 
phenotypes and, as previously mentioned, organizational and activational androgen 
administration is the most critical distinction between pre- and postnatal PCOS models.  
Other physiological changes that are important to metabolic and endocrine 
changes associated with PCOS include vaginal opening and anogenital distance measures.  
Marking the beginning of the estrous cycle, vaginal opening typically occurs at the fifth 
postnatal week (Rodriguez, Araki, Khatib, Martinou, & Vassalli, 1997); however, this 
opening has been found to occur earlier in some PNA models of PCOS (Roland et al., 
2010).  Rodriguez et al. (1997) found that mouse models would undergo vaginal opening 
earlier if they were exposed to an estrogen precursor.  It seems, then, that hormone 
regulation is important for vaginal opening. Prenatal models of PCOS have not reported 
vaginal opening as a standard measure. Schober, Dulabon, Martin-Alguacil, Kow, and 
Pfaff (2006), in a study unrelated to PCOS, reported vaginal fusion in young girls and 
describe it as fusion of the labia together and red tissue surrounding the vagina. Schober 
et al. also discussed the function of lower levels of estrogen at birth playing a role in the 
vaginal fusion event.  Connecting this concept to the study done by Rodriguez and 
colleagues, if PNA mice have elevated testosterone and lower levels of estrogen, then, the 
lack of vaginal opening is a reasonable outcome given that reproductive hormone 
dysfunction could result in vaginal fusion. Cases of vaginal fusion may be underreported 
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in PCOS animal models.  In addition, anogenital distance, which is normally longer in 
males, is a measure that increases in women exposed to androgens during in utero 
development (Wu, Zhong, Chen, Zheng, Liao, & Xie, 2017). One prenatal PCOS rat 
model found that PNA-treated subjects had longer anogenital distance (Wu et al., 2010).  
Because PCOS is characterized by increased testosterone in females, measuring 
anogenital distance has become a validation measurement for the model.  Both vaginal 
opening and anogenital distance are sensitive physiological metrics for reproductive 
hormone changes.  
PCOS models also vary in their utilization of testosterone and related hormones to 
simulate different processes of the disease. Caldwell et al. (2014) identified “4 distinct 
hyperandrogenized models,” that include “androgens, estrogens, aromatase inhibitors, 
antiprogestines, changes in light exposure, and genetic manipulations” (p. 3147). 
Testosterone, in healthy women, is processed by the enzyme aromatase into estrogen; 
thus, estrogen and aromatase levels are typically higher in females (Goodarzi et al., 2011). 
Interrupting the process of converting testosterone to estrogen is accomplished by using 
dihydrotestosterone (DHT) or dehydroepiandrosterone (DHEA) derivatives that remain 
as testosterone. As a reminder, serum testosterone levels are higher in women with PCOS.  
The purpose of these models is to alter biological processes and produce excess 
androgens to simulate PCOS.   
Walters, Allan, and Handelsman (2012) summarized the effects of DHEA on 
metabolic and reproductive symptoms. DHEA is similar to DHT in that both are 
derivatives of testosterone and will not convert to estrogen in women.  The authors 
suggested that recent research has utilized DHEA models for studying “acyclicity, 
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abnormal maturation of ovarian follicles, and anovulation” (p. 1).  DHEA is primarily 
used in postnatal models. For example, Walters et al. (2012) reviewed the literature on 
several postnatal DHEA rodent models, and found these studies consistently produced 
irregular or acyclic estrus cycles and ovarian cysts. Another review of PCOS animal 
models emphasized that DHEA, as a long-term postnatal treatment, is “the best approach 
to simulate the breadth of reproductive, endocrine, and metabolic features of human 
PCOS” (Caldwell et al., 2014, p. 3155). In regards to DHEA, Caldwell et al. found 
effects on androgen levels to approach higher levels in the DHEA postnatal model 
compared to DHEA in the prenatal model. As mentioned previously, Caldwell and 
colleagues (2014) studied DHEA and DHT in both pre- and postnatal models.  
 The other commonly studied model for simulating excess androgen uses DHT, a 
derivative of testosterone. Unlike DHEA, which has mostly been examined in postnatal 
models, DHT has been examined in both pre- and postnatal models. Caldwell et al. 
(2014) demonstrated that DHT animal models resulted in fewer completed estrous cycles, 
reduced ovary weight, and a significantly higher percentage of unhealthy follicle cells.  
DHT has also been found to produce features of ovarian morphology similar to PCOS 
with unhealthy follicles and atretic cyst-like formations (Caldwell et al., 2014). 
Additionally, DHT in prenatal models mimics “androgen excess… of human PCOS” 
closely (Caldwell et al., 2014, p. 3156).   Thus, based on the current literature, DHT is 
supported as a prenatal model of PCOS.   
In conclusion, both pre- and postnatal models have been used to simulate PCOS 
physiological phenotypes in animals.  Recently, Yu and colleagues (2016) studied brain 
structure and monoamines in relation to the effects of androgens (i.e., mimicking PCOS) 
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on depression and mood disorders. Nonetheless, research on the relationship between 
psychological disorders and PCOS is limited to only a few studies. In prenatal models, 
researchers have historically examined biological PCOS effects, but studies on the 
psychological symptoms of PCOS have been published recently. Determining the 
interplay between these areas of symptomology is important to increase PCOS 
knowledge and to further understand PCOS models.   
Behavioral Models.  In order to understand the impacts of PCOS in humans, 
researchers have used behavioral models to observe emotional and psychological distress 
in animal subjects. Animal models such as the elevated zero maze (EZM) and forced 
swim test have predictive validity for research in biomedical fields (Yan, Cao, Das, Zhu, 
& Gao, 2010; Bell, Duke, Gilmore, Page, & Begue, 2013). Therefore, pharmaceutical 
companies have validated these models of anxiety- and depression-like behavior to 
investigate potential clinical anxiolytic and antidepressant drug efficiency.  Such 
behavioral models are short tests (e.g., 5- or 15-minute intervals) and consist of coding 
inactivity or activity changes across the time-period (Castagne, Moser, Roux, & Porsolt, 
2011). For example, forced swim tests in which time spent struggling in a small, room-
temperature pool of water is measured, have been validated for their ability to predict 
clinical efficacy of antidepressant medications, namely fluozetine, in humans. 
Antidepressant efficacy in clinical trials is correlated with decreased time spent immobile 
in the forced swim apparatus in mice that received a single acute pre-administration of 
the drug (Page, Detke, Dalvi, Kirby, & Lucki, 1999). 
It is important to note that these behavioral models for anxiety- and depression-
like behaviors also show face validity (i.e., giving up and not swimming or struggling on 
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the forced swim test resembles hopelessness) as well as pharmaceutical predictive 
validity. For example, the EZM is a circular maze consisting of two open and two closed 
sections.  Rodents appear to prefer the closed sections and, under standard conditions, 
spend more time in those sections. Time spent in the open sections is interpreted to reflect 
decreased anxiety-like or fear-like behavior; an interpretation further supported by 
findings that anxiolytic medications increase the percentage of time spent in open-arms of 
the maze (Shepherd et al., 1994). Other behavioral changes on the EZM which include 
exploratory behavior such as head-dips, rearing, and stretched attend posture are also 
sensitive to anxiolytic manipulation (Molewijk, van der Poel, & Oilvier, 1995).  Given 
that behavior on the EZM and forced swim test changes in predictable ways in response 
to anxiolytic and antidepressants agents, respectively, these models are commonly used 
as measures of anxiety and depression.  
In investigating behavioral changes in a prenatal PCOS model (i.e., PNA mice), 
Yu et al. (2016) utilized the forced swim and tail suspension test to observe “depression-
like behavior” (p. 1) and the open field test to investigate activity and anxiety-like 
behavior. Yu et al. found that PCOS animals exhibited significantly increased immobility 
on both the forced swim and tail suspension tests, which is interpreted as depression-like 
behavior.  On the open field test, PNA mice had significantly lower activity levels. 
Therefore, these findings indicate that animal models of PCOS may show behavioral 
changes, including lower activity levels and higher depression-like behavior. 
Another related study administered DHT in a rat prenatal model examined 
anxiety-like behavior in the offspring (Hu et al., 2015).  These researchers found a 
significant decrease in activity in the open arms of the EZM in PCOS animals compared 
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to controls. Likewise, Ressler and colleagues (2015) discovered mice treated with DHT 
postnatally exhibited anxiety-like behavior represented by decreased time spent in the 
open arms of an EZM. Additionally, this same study found increased immobility for PNA 
mice on a forced swim test. Taken together, these findings suggest that animals exposed 
to treatments designed to model PCOS show alterations in anxiety- and depression-like 
behaviors: however, such investigations have not been widespread nor have they 
considered the additional effects of stress on behavior. 
Order effects. Behavioral test history and carryover effects in test batteries have 
been previously reported in animal research. The prevailing rule of thumb has been that 
less invasive tests should be conducted first, followed by more invasive testing (i.e., 
Blokland et al., 2012; McIlwain, Merriweather, Yuva-Paylor, & Paylor, 2001; Voikar, 
Vasar, & Rauvala, 2004).  It is important to understand the differences between test naive 
and experienced mice when running behavioral tests.  Voikar, Vasar, & Rauvala (2004) 
found that naive C57BL/6J mice took a significant shorter time to enter open areas of an 
elevated plus maze and spent a longer amount of time in open arms.  The elevated plus 
maze is similar to the EZM and this finding is important for interpreting the results of the 
current research. Whereas these carryover effects may occur in the elevated plus maze, 
McIlwain et al. (2001) found that carryover effects were test dependent, limiting 
generalizations across tests.  In considering the possibility of carryover effects and test 
history, the current research followed the concept of using the least invasive test first, 
followed by the more invasive test.  
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Animal Models and Stress 
As previously mentioned, acute stress is temporary, whereas chronic stress is 
more prolonged and, often, more pronounced than normal day-to-day stress functions.  In 
humans, the nature, number, and persistence of stressors are associated with the onset and 
relapse of psychological disorders as well as the intensity of symptomology 
(Schneiderman, Ironson, & Siegel, 2005). However, stress responses are also adaptive 
and serve as a biological mechanism for regulating basic bodily processes and fight-or-
flight fear responses (Mastorakos, Pavlatou, & Mizamtsidi, 2006). One interesting study, 
found that chronic stress exposure had physiological changes that were similar to a PCOS 
phenotype (Divyashree & Yajurvedi, 2016).  In this model, after 12 weeks of stress 
exposure, the stress condition mice showed lower body weights, increased adrenal gland 
weights, and elevated serum corticosterone. There are multiple physiological measures 
that can be taken to validate a stress model, and these models can also be created in 
various ways.   
Examining stress in animal models can take various forms. One such example 
uses physical restraint to induce stress.  Divyashree and Yajurvedi (2016) recently used 
an “open-ended cylindrical glass restrainer” and forced swim test to induce chronic stress 
in rat subjects (p. 766).  In that study, chronic stress resulted in increased adrenal gland 
activity, cortisol concentration, and decreased body weight after eight weeks of stress. 
Similar studies have used other forms of stress models, including but not limited to cold-
restraint exposure, physical restraints, and social defeat stress (Divyashree & Yajurvedi, 
2016; Golden, Covington, Berton, & Russo, 2011). 
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Such physical stressors may represent environmental stress, however, such studies 
have yielded conflicting results.  For example, Golden and colleagues (2011) used a 
social defeat paradigm that produced stress-related behavior as measured by social 
interaction and avoidance; however, the authors suggested they might have, instead, 
modeled depression-like behavior. Even in human research, the concept of stress as a 
scientific idea continues to evolve as researchers acknowledge that stress does not exist 
as a uniform response to challenges to homeostasis but that, in fact, different stressors 
induce difference patterns of sympathetic and HPA activity (Goldstein & Kopin, 2009). 
Thus, when investigating the impact of cortisol and/or HPA activity, one possible remedy 
to inconsistent results and variations in models of stress would be to use cortisol or 
corticosterone pellets to induce a steady-state elevation in glucocorticoids. 
Hermann and colleagues (2009) compared the effectiveness of administering 
corticosterone with subcutaneous injection, implantation of hormone-releasing pumps, 
and implantation of slow-release pellets.  Administering corticosterone via pellets 
appeared to maintain consistent plasma levels with rapid increases in corticosterone 
within hours of administration. However, these authors discussed the need to replace 
corticosterone pellets after 7 and 14 days to maintain heightened and consistent 
corticosterone levels. Importantly, Hermann and colleagues measured corticosterone 
levels on a daily basis, and demonstrated a narrow range of levels between subjects (i.e., 
1200 and 1400 μg/L) with low variation between subjects.  Thus, in regards to evaluating 
the physiological and behavioral effects of HPA activation, using corticosterone pellets 
provides the most control and consistency over corticosterone levels which may be more 
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desirable for reasons of internal validity. As was done by Herrmann et al., it is necessary 
to measure serum levels of corticosterone to verify the validity of the treatment.  
Hypotheses 
  The purpose of the current study was to investigate the potential of a mouse 
model of PCOS, in particular a model using prenatal administration of DHT, to induce 
excessive androgen levels and to examine the physiological and psychological symptoms 
associated with PCOS.  The impact of elevated corticosterone (CORT) in both PCOS and 
control mice was also evaluated.  It was hypothesized that PNA mice would show more 
anxiety- and depression-like behaviors than prenatal saline mice due to organizational 
changes produced by androgen elevation in the prenatal PCOS mouse model. It was 
further anticipated that inducing stress-like conditions in mice would produce heightened 
anxiety- and depression-like behaviors, but that those effects would be more pronounced 
in animals that had been prenatally exposed to androgen (i.e., PNA or PCOS-model mice).  
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CHAPTER III 
 
 METHODS 
 
Subjects 
The current study’s prenatal model of PCOS used C57BL/6J mice because of 
their applicability in comparative studies and because C57BL/6J dams are successful 
breeders as measured by litter size and survival rates (Weber, Hultgren, Algers, & Olsson, 
2016).  Additionally, C57BL/6J mice demonstrate moderate baseline activity levels 
appropriate for behavioral measures (de Visser, van den Bos, Kuurman, Kas, & Spruijt, 
2006). Twenty-four female C57BL/6J mice were obtained from Jackson Laboratory 
along with males for breeding purposes.  Dams were randomly assigned to the DHT or 
saline conditions, with successful pregnancies in 10 and 6 dams, respectively.  Breeding 
proceeded in two separate rounds. The first round of breeding produced 10 DHT and 12 
prenatal saline female offspring. For the second round of breeding, we obtained 11 DHT 
and 4 prenatal saline female offspring. The resulting number of subjects for each 
experimental condition were: n = 12 (PNA-CORT), n = 9 (PNA-Control), n = 5 (Prenatal 
Saline-CORT), and n = 11 (Prenatal Saline-Control). Central Washington University’s 
Institutional Animal Care and Use Committee approved all experimental procedures 
(Protocol #). 
Care and Housing. Animals were housed in climate-controlled (i.e., 75-77o F), 
12-hour light/dark cycle rooms. Initial housing and breeding occurred in the Science 
Building vivarium at Central Washington University. Animals were pair-housed with 
same-sex animals in the same condition in clear polypropylene cages (22.2 x 30.80 x 
16.24 cm) and provided with CareFresh bedding (Kaytee Aspen Bedding), Mazuri rodent 
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diet chow (6F), and water ad libitum.  After weaning and pellet implantation, mice were 
transferred to the Department of Psychology vivarium, with conditions matched to the 
Science vivarium. The principle investigator was responsible for animal care, including 
daily cage checks and weekly cage changing.  
 Dams and Breeding.  Female C57BL/6J mice were used in a time-mating 
protocol, which ensured the offspring for testing were born within a two-day period. 
Male C57BL/6J mice were paired with a female mouse for two consecutive evenings. 
Breeding occurred in the familiar cage of the female. In order to determine gestation date, 
dams were checked daily for the presence of copulation plugs; the presence of such a 
plug designated day 0 of gestation.  Dams delivered pups at day 19.5 to 20.5.  Once litters 
were produced, the pups remained with their dam until weaning on postnatal day 21 
(PN21).  
Physiological Measures. Seven days after birth, group weights of female pups 
were taken for each treatment group.  This method of body weight was continued for 
PN14 and PN21. After weaning on PN21, individual weights were taken once a week 
until undergoing pellet surgery on PN36. During surgical recovery, female offspring were 
weighed daily until behavioral testing.  Final weights were taken immediate to euthanasia. 
Vaginal openings were checked daily after weaning and until all subjects showed 
openings or until surgery, whichever came first. For some subjects, qualitative reports of 
vaginal redness were collected. Anogenital distance was measured for all subjects after 
euthanasia.   
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Materials 
 PNA Model. At day 0 of gestation, dams were randomly assigned to either the 
PNA or saline group. Following a protocol from Caldwell et al. (2014), dams in the PNA 
condition received DHT (i.e., 250 μg) prepared in sesame oil, which was administered 
subcutaneously in a volume not exceeding 100 μL per injection. Saline was also prepared 
in sesame oil and administered in 100 μL injections. The DHT and saline injections were 
administered on days 16-18 of pregnancy.  The DHT treatment is designed to produce 
organizational changes in the dam’s female offspring that result in a mouse model of 
PCOS in those offspring. 
Stress Model.  Female offspring of each litter were randomly assigned to CORT 
pellet or a control pellet treatment.  CORT pellet preparation followed a published 
protocol using low-cost pellets (Sahores et al., 2013).  Referring to Sturm, Becker, 
Schroeder, Bilkei-Gorzo, and Zimmer (2015), 20 mg of corticosterone was used in the 
pellets.  Following Sahores et al.’s (2013) protocol, 600 mg corticosterone was mixed 
with 3.6 mg of silicone adhesive.  Control pellets were made using only silicone adhesive.  
CORT pellets were pressed and kept overnight between glass slides.  The pellets were, 
then, cut into equal 4 mm diameter pieces.  Surgery and subcutaneous implantation of 
CORT pellets were followed by use of vet bond and a staple to close the wound. Subjects 
were allowed seven days of recovery before conducting behavioral tests. In future studies, 
serum CORT levels will be measured in subjects to verify this model.  
Behavioral Models 
Some models for psychological disturbances in mice include the EZM and forced 
swim test, which provide operationalized variables of anxiety, depression, and baseline 
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activity. Behavioral testing occurred between PN43 to 47 for female offspring. Each 
behavioral model measured subject activity in 5 min increments. Subject activity was 
recorded using a video camera placed above or across from the apparatus. Trained 
observers coded activity of mice after all behavioral testing was complete.  To ensure 
reliability, scores for each video came from the average of two coders.  Scores needed to 
be in 70% agreement or higher to be included in the average. If the agreement was below 
70%, a third coder’s data were, instead, used in the average calculation.  If 70% 
agreement was not achieved after the third coder, the average per condition and time 
interval was included.  To clarify, if a PNA-CORT subjects’ score for minute 1 did not 
reach 70% agreement then the average for all other subjects in both PNA and CORT 
treatment conditions for that minute was averaged and included in that cell.  
EZM. The EZM measures anxiety-like behavior based on the time spent in open 
compared to closed areas as well as providing measures of total activity in the form of 
total arms entered.  Subjects in all four experimental conditions (i.e., PNA-CORT, PNA-
Control, Prenatal Saline-CORT, Prenatal Saline-Control) underwent the EZM first. The 
EZM apparatus was elevated 50 cm off the floor and is an annular maze (e.g., circular). 
The maze was 60 cm in diameter and consists of four distinct quadrants.  Open quadrants 
and closed quadrants, with ~28 cm clear acrylic walls, are opposite each other in the 
EZM maze. See Appendix A for an image of the EZM. Mice were placed in the maze for 
5 min. Lumens in the open areas were approximately 22 to 40 lux and in the closed areas 
were 6 to 10 lux. Movement between closed and open areas and time spent in the open 
and closed arms were coded. An entry into an open arm occurred if the mouse crossing 
all 4 paws into the open arm. Counting the number of entries into closed and open arms 
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followed the same requirement; that all 4 paws needed to cross into the new arm. If mice 
spend time mostly in closed areas, this is interpreted as indicative of anxiety-like 
behavior. Again, this behavioral model has predictive validity for pharmaceutical drugs, 
such as anxiolytics. Each subject was tested on the EZM before testing on the forced 
swim apparatus. 
Forced swim. As a test of depression-like behavior, subjects in all four 
experimental conditions (i.e., PNA-CORT, PNA-Control, Prenatal Saline-CORT, 
Prenatal Saline-Control) underwent a forced swim test 24 hr after the EZM. Mice were 
placed in a 5000 mL container of room-temperature water. The container was filled with 
3500 mL of water so the mouse could not touch the bottom or climb out. See Appendix A 
for an image of the forced swim apparatus. Mice naturally can swim; however, they 
prefer to escape water. Mice can either choose to swim (e.g., attempt to get out) or float.  
Floating behavior is coded as immobility and is taken at face value to resemble 
hopelessness behavior (i.e., depression-like behavior). Floating behavior was coded, 
resulting in immobility data for each of the 5 min of the test. Floating was determined if 
the animal was not propelling through the water and only had minimal paw movements 
(i.e., only paw movement to stay above water not to propel it through the water). As 
discussed previously, the forced swim test has been validated as a depression-like 
behavioral model for testing antidepressant drugs. 
Design  
PCOS was operationalized in the current experiment by the concept of prenatal 
exposure to androgen excess. More specifically, female mice in the experimental group 
should have mimicked PCOS symptomology following the prenatal administration of 
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DHT (i.e., a testosterone derivative).  Body weight measures were collected weekly to 
determine percent body weight changes, as other studies have found differences in body 
weight in response to DHT or CORT treatment, separately. As mentioned, vaginal 
opening determines sexual maturity in female subjects.  After euthanasia, anogenital 
distance was measured to determine if prenatal exposure to androgen resulted in larger 
anogenital distances compared to control subjects. 
Measures of depression- and anxiety-like behavior were collected for all subjects 
to compare psychological effects of prenatal treatment (i.e., PNA, Prenatal Saline) and 
postnatal stress condition (i.e., CORT, Control). Overall, it was expected that mice in the 
DHT group would spend less time in the open arms of the EZM (i.e., increased anxiety-
like behavior) and have higher levels of immobility in the forced swim test (i.e., 
increased depression-like behavior). Each subject completed the EZM and, then, after 24 
hr, the forced swim test. As noted, for each test, data were collected for each minute of 
the 5 min test to determine if behavioral patterns rather than overall behavior differed 
across conditions. Therefore, 2 (PNA, Prenatal Saline) x 2 (CORT, Control) x 5 (1-5 min) 
mixed ANOVAs were used to analyze behavior on the EZM and immobility on the FST.  
In other words, each behavioral measure followed a repeated measures design of activity 
and immobility (i.e., repeated measures were scored at each minute in the interval).  
Statistical Analysis 
As previously noted, behavioral data consisted of averages from two coders per 
video recording. On measures in which coders did not show over 70% agreement, a third 
coder’s data were included in the average. Lastly, when 70% was not reached, the 
average score for the condition and time interval was included.  
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Mixed factor ANOVAs examined the effects of PNA and postnatal CORT 
administration on behavioral measures in all subjects. When appropriate, an additional 
factor of minute in the test (i.e., 1-5 min) was utilized, for resulting separate 2 (PNA, 
Prenatal Saline) x 2 (CORT, Control) x 5 (1-5 min) ANOVAs to analyze time spent in 
the open arms of the EZM, total arm entries on the EZM, and immobility on the forced 
swim test.  As noted, increased time in the open arms is interpreted as decreased anxiety-
like behavior while increased immobility on the forced swim test is interpreted as 
depression-like behavior.  Bonferroni correction was used as a post-hoc analysis for all 
statistics. 
Physiological measures were analyzed using separate independent samples t-tests 
or ANOVAs.  The physiological measures and analysis included the number of pups born 
to each treatment condition dam (independent samples t-test), which was collapsed within 
each cage to account of pair housing of dams. Weights before pellet implantation [2 
(PNA, Prenatal Saline) x 3 (PN7, PN14, PN21) ANOVA], final weight at the time of 
euthanasia [2 (PNA, Prenatal Saline) x 2 (CORT, Control) ANOVA], vaginal opening 
[(PNA, Prenatal Saline) ANOVA], and anogenital distance [2 (PNA, Prenatal Saline) x 2 
(CORT, Control) ANOVA], were also analyzed.  Two analyses were included for vaginal 
opening. The first measured the percentage of true vaginal opening in subjects for each 
group. The second counted vaginal opening as the first day of the qualitative observation 
of red tissue around the vagina (i.e., vaginal redness) and, similarly, used percentage of 
opening for each treatment condition. Bonferroni correction was used as a post-hoc 
analysis.   
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CHAPTER IV 
 RESULTS 
The total number of animals in each condition ranged from 5 to 12 (PNA-CORT: 
n = 12; PNA-Control: n = 9; Prenatal Saline-CORT: n = 5, and Prenatal Saline-Control: n 
= 11).  There was a non-significant trend for fewer female pups in DHT-treated (M = 3.5, 
SD = 1.38) compared to prenatal saline-treated (M = 5.33, SD = 1.53) litters, t(7) = 1.83, 
p = .056. As a reminder, litters were collapsed within each pair housed cage of dams. 
Data for body weights, vaginal openings/vaginal redness, anogenital distances, forced 
swim immobility, and time spent in the open arms and total arm entries in the EZM are 
discussed below. 
Body Weight 
PNA and prenatal saline pups were not significantly different in body weight 
before weaning an analyzed by a 2 (PNA, Prenatal Saline) x 3 (PN7, PN14, PN21) 
ANOVA; however, there was a significant main effect of PN day, F(2, 14) = 44.71, p 
< .001, with a post-hoc comparison indicating that body weights increased significantly 
across days, ps < .05, as shown in Table 1. Body weights were also collected daily after 
pellet implantation and the average body weight across those days was analyzed via a 2 
(PNA, Prenatal Saline) x 2 (CORT, Control) ANOVA, which found no significant effects 
or interaction, as shown in Figure 1. For body weight at euthanasia, the prenatal condition 
did not significantly affect body weight, but postnatal pellet implantation did significantly 
influence body weight, F(1, 33) = 5.22, p < .05, with the CORT condition having lower 
body weights as shown in Table 2. 
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Table 1 
Average Female Body Weights (g) at PN7, PN14, and PN21 
Group n PN7 
M (SD) 
PN14 
M (SD) 
PN21 
M (SD) 
PNA 21 4.94 (2.45) 7.22 (1.21) 8.33 (1.64) 
Prenatal- Saline  16 4.60 (1.72) 6.84 (0.73) 8.15 (0.92) 
 
Table 2 
Average Body Weights (g) at Time of Euthanasia 
Group n M (SD) 
    PNA-CORT 12  17.67 (0.68) 
    PNA-Control 9  18.33 (0.72) 
    Prenatal Saline-CORT 5  17.52 (1.23) 
    Prenatal Saline-Control 11  18.45 (0.93) 
 
 
Figure 1. Average body weights (g ± SEM) at time of euthanasia collapsed across 
prenatal conditions. *Difference between CORT and control, p < .05. 
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Vaginal Openings 
An ANOVA for the factor of prenatal treatment on vaginal opening did not reveal 
any differences. However, PNA mice showed vaginal redness in some cases, as described 
previously, instead of vaginal opening. If the redness were coded as the day of vaginal 
opening, then prenatal treatment did significantly affect vaginal opening (i.e., vaginal 
redness), F(1, 35) = 6.04, p < .05, as shown in Figure 2. Of the PNA mice, 50% showed 
vaginal opening or vaginal redness at day 4, whereas 50% of prenatal saline mice showed 
vaginal opening later at day 8. At day 8, 100% of PNA mice showed vaginal opening or 
vaginal redness, whereas prenatal saline mice reached 100% vaginal opening at day 13. 
 
Figure 2.  Percentage of subjects on each post-weaning day showing vaginal opening or 
vaginal redness (for PNA subjects); differences between PNA and prenatal saline as 
noted in text.  
Anogenital Distance 
A 2 (PNA, Prenatal Saline) x 2 (CORT, Control) ANOVA for anogenital distance 
immediately after euthanasia revealed a significant effect of prenatal treatment, F(1, 29) 
0
20
40
60
80
100
120
1 2 3 4 5 6 7 8 9 10 11 12 13
P
er
ce
n
ta
g
e 
o
f 
S
u
b
je
ct
s
Postnatal Day After Weaning
PNA
Prenatal-
Saline
  
 
31 
= 6.79, p < .05, but no effect of postnatal manipulation nor an interaction. PNA mice had 
significantly longer anogenital distances than prenatal saline mice, as detailed in Table 3. 
Data is collapsed within prenatal treatment groups (i.e., PNA and Prenatal Saline).  
Table 3 
Average Anogenital Distance (mm) at Euthanasia  
Group n M (SD) 
PNA 20 5.9 (1.0) 
Prenatal-Saline 13 5.0 (0.4) 
 
EZM and Anxiety-like Behavior 
Time Spent in the Open Arms. Outliers, represented by scores greater or less 
than two standard deviations from the mean of each condition, were removed prior to 
analysis, resulting in n = 10, n = 7, n = 5, and n = 9 for the PNA-CORT, PNA-Control, 
Prenatal Saline-CORT, and Prenatal Saline-Control conditions, respectively.  
A 2 (PNA, Prenatal Saline) x 2 (CORT, Control) x 5 (1-5 min) ANOVA revealed 
a significant main effect of test minute on time spent in the open arms, F(4, 108) = 3.42, 
p < .05, in addition to a test minute x prenatal treatment interaction, F(4, 108) = 2.71, p 
< .05. A post-hoc comparison of the interaction revealed no differences among prenatal 
conditions at any specific test minute but did reveal that time spent in the open arms 
increased significantly from test minute 2 to test minute 3 and from test minute 3 to test 
minute 4, ps < 0.05, as detailed in Table 4. Follow up ANOVAs were conducted for the 
factors of prenatal and postnatal treatments at each of the 5 test minutes, with only test 
minute 4 yielded a significant difference between prenatal treatments, F(1, 29) = 314.08, 
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p < .05. PNA subjects showing increased time spent in open arms of the maze. Mean and 
standard deviations collapsed across postnatal treatment conditions into PNA and 
prenatal saline groups, M = 11.53, SD = 7.5, and M = 5.56, SD = 6.3, respectively. 
Table 4 
Time Spent in Open Arms (sec) in the EZM by Test Minute and Group 
Groups n Minute 1 
M (SD) 
Minute 2 
M (SD) 
Minute 3 
M (SD) 
Minute 4 
M (SD) 
Minute 5 
M (SD) 
 
PNA-CORT 
 
 
10 
 
3.6 (6.3) 
 
2.9 (4.1) 
 
6.2 (6.7) 
 
9.0 (9.2) 
 
 
6.9 (6.2) 
 
PNA-Control 7 5.5 (5.0) 3.6 (4.0) 
 
4.2 (7.2) 
 
14.4 (5.8) 
 
5.0 (2.5) 
 
Prenatal Saline-CORT 5 3.4 (5.5) 
 
4.7 (7.2) 
 
4.8 (6.2) 
 
8.4 (7.5) 
 
13.3 (9.0) 
 
Prenatal Saline-Control 
 
9 4.6 (6.1) 
 
4.1 (5.2) 
 
8.8 (7.9) 
 
2.8 (3.6) 
 
7.5 (7.4) 
 
 
Total Entries into Arms.  Analysis of total entries into arms on the EZM did not 
reveal any significant effects of prenatal or postnatal treatments nor on test minute on the 
apparatus as partially depicted in Table 5. 
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Table 5 
Total Entries into Open and Closed Arms on the EZM 
Groups n Open Arms Entries 
M (SD) 
Closed Arms Entries 
M (SD) 
 
PNA-CORT 
 
10 
 
7.1 (4.2) 
 
6.8 (4.6) 
PNA-Control 7 7.0 (2.6) 6.2 (2.8) 
Prenatal Saline-CORT 5 5.6 (2.2) 4.9 (2.4) 
Prenatal Saline-Control 9 4.8 (2.6) 4.9 (2.8) 
Forced Swim Test: Depression-like behavior 
Outliers, represented by scores greater or less than two standard deviations from 
the mean of each condition, were removed prior to analysis, resulting in n = 9, n = 7, n = 
4, and n = 11 for the PNA-CORT, PNA-Control, Prenatal Saline-CORT, and Prenatal 
Saline-Control conditions, respectively. 
A mixed 2 (PNA, Prenatal Saline) x 2 (CORT, Control) x 5 (1-5 min) ANOVA 
for immobility on the forced swim test revealed a significant main effect of test minute, 
F(4, 108) = 104.43, p < .001; post-hoc comparisons revealed increases in immobility 
across the test such that test minute 1 had less immobility than test minutes 2-5 and test 
minute 2 had less immobility than test minutes 3-5, ps < .001, as detailed in Table 6.  
There was also a significant effect of prenatal manipulation, F(1, 27) = 9.30, p < .01, with 
PNA animals having lower immobility than prenatal saline animals, as depicted in Figure 
3.  Prenatal manipulation for the total time spent immobile is collapsed across postnatal 
treatments, for example, PNA-CORT and control treatments combined and prenatal 
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saline-CORT and control treatment (M = 19.25, SD = 12.26 and M = 27.79, SD = 14.54, 
respectively).  
Table 6 
Immobility Time (sec) by Test Minute and Group on the Forced Swim Test 
Groups n Minute 1 
M (SD) 
Minute 2 
M (SD) 
Minute 3 
M (SD) 
Minute 4 
M (SD) 
Minute 5 
M (SD) 
PNA-CORT 9 1.4 (1.5) 14.2 (4.7) 22.1 (5.0) 25.1 (6.4) 26.7 (9.0) 
PNA-Control 7 1.9 (1.5) 14.7 (7.2) 23.8 (11.8) 33.7 (7.3) 30.7 (6.7) 
Prenatal 
Saline-CORT 
4 4.1 (1.7) 22.3 (9.2) 35.0 (5.6) 36.1 (9.9) 31.4 (5.5) 
Prenatal 
Saline-Control 
11 2.3 (1.4) 18.6 (9.6) 31.5 (9.6) 33.1 (10.4) 36.2 (8.2) 
 
 
 
Figure 3. Time (sec  SEM) spent immobile in the forced swim test by prenatal condition.  
Prenatal condition (PNA or Prenatal-Saline) is collapsed across postnatal stress (CORT 
or control) conditions. *Difference between PNA and prenatal saline animals, p < .01.   
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CHAPTER IV 
DISCUSSION 
 In the current study, the PNA model resulted in decreased anxiety-like (i.e., 
increased time in the open arms on the EZM at test minute 4) and depression-like (i.e., 
decreased time spent immobile in the forced swim test) behavior. Neither decreased 
anxiety-like behavior on the elevated zero maze nor, decreased depression-like behavior 
on the forced swim test was expected in PNA mice. Effects of the prenatal model were 
observed on the physiological measures of vaginal redness and anogenital distance with 
earlier vaginal redness and longer anogenital distances in PNA mice compared to saline 
controls. The postnatal treatment also altered body weight at the time of euthanasia, with 
animals who were implanted with a CORT pellet having lower body weight than animals 
implanted with a control pellet. Applications of the current findings to future research 
will be important for understanding the interconnections between PCOS and mental 
illness.  In addition, limitations of the current study may be overcome in future research. 
PNA Model and Anxiety-like behavior 
As noted, PNA-treated mice showed decreased anxiety-like behavior during the 
4th minute of the EZM test and did not alter activity levels as measured by total arm 
entries. These findings do not support the hypothesis that our PCOS model or our 
postnatal stress condition would result in increased anxiety-like behavior. Given that 
prior research has demonstrated the EZM to be a sensitive measure for anxiety-like 
behavior in rodents (Bell et al., 2014), it might be argued that the current prenatal PCOS 
model did not alter anxiety-like behavior. Our prenatal PCOS and stress manipulations 
did not impact anxiety-like behavior as expected. The lack of expected findings may be 
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due to differences in lab protocols for measuring anxiety-like behavior (i.e., different 
anxiety-like testing procedures). 
As previously noted, Ressler et al. (2015) found total percent time spent in the 
open arms to be significantly different between control and DHT-treated animals on the 
EZM, supporting a conclusion of increased anxiety-like behavior in a PCOS animal 
model. The contradictory findings in the current study may be due to differences in the 
timing of DHT treatment (i.e., postnatal vs. prenatal, respectively) between Ressler et 
al.’s study and the current research. The etiology of anxiety and depression in PCOS 
might not be due to developmental factors but, instead, to environmental or epigenetic 
changes that occurs after birth, allowing Ressler et al. (2015) to find changes in his 
postnatal model because elevating testosterone levels postnatally have a stronger impact 
on the stress system and, subsequently, on anxiety-like behavior. 
The EZM analysis only coded the total amount of time spent in the open arms and 
the number of total arm entries. However, exploratory behavior on the EZM may also 
provide useful measures of anxiety-like behavior (Rodgers, Cao, Dalvi, & Holmes, 1997). 
Commonly reported exploratory behaviors include head dips (i.e., looking over the side 
of the maze) and stretch-attend posture (i.e., extended posture and minimal movement; 
Molewijk, van der Poel, & Olivier, 1995). For example, protected-head dipping and 
sniffing in the closed area, in a factor analysis, loaded highly with anxiety (Rodgers et al., 
1997). Another study found that a dose of the anxiolytic drug, diazepam, increased the 
number of open arm entries as well as head dips in the open areas but decreased the 
frequency of stretch-attend postures (Matto, Harro, & Allikmets, 1997). Thus, head dips 
in the open arms might be interpreted as decreased anxiety-like behavior, but increased 
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stretch-attend postures and closed-arm head dipping might indicate increased anxiety-like 
behavior (Rodgers et al., 1997). Studying exploratory behaviors may provide more 
nuanced measures of anxiety-like behavior in rodent models and, therefore, future studies 
should consider coding these measures. 
PNA Model and Depression-like Behavior 
Behavior on the forced swim test in the current study aligned with prior reports of 
increased immobility across time on this behavioral test (Petit-Demouliere, Chenu, & 
Bourin, 2005). With approximately 4,300 published papers using the forced swim test, it 
appears to be a popular measure for depression-like behavior (Molendijk & de Kloet, 
2015). Despite the ubiquitous use of the forced swim test, neither prenatal nor postnatal 
manipulations associated with DHT and CORT, respectively, changed immobility as 
expected in the current study. In fact, contrary to our expectation, PNA mice showed 
lower immobility than prenatal saline controls (i.e., less depression) while our postnatal 
manipulation did not have any effects on immobility.  
Previous studies have found increased immobility in postnatal models of PCOS 
(Yu et al., 2016), suggesting that, similarly to our findings regarding anxiety-like 
behavior, postnatal but not prenatal DHT treatment may yield PCOS models that more 
strongly impact behavior. Yu et al. (2016) also correlated changes on their behavioral 
tests to decreased levels of dopamine, serotonin, and norepinephrine in their DHT-treated 
animals, indicating potential neurochemical mechanisms that could underlie the observed 
behavioral changes. Using measures of neurotransmitter function may be particularly 
relevant as a biological endpoint and collecting brain tissue samples in a prenatal model 
of PCOS may be an important step in the development of PCOS animal models.  The 
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majority of PCOS research focuses on metabolic features of the disorder and examining 
psychological components of the disorder in animals remains a novel and relatively 
recent pursuit, resulting in limited information on brain-related changes. Investigating 
changes in neurochemistry would be an important step to understanding the etiology of 
depression or other mental illness in PCOS. 
A recent publication further complicates our ability to interpret the current 
findings in that that article calls into doubt the use of the forced swim test as a true 
measure of depression-like behavior (Molendijk & de Kloet, 2015). According to those 
authors, the forced swim test more accurately represents a response to an acute stressor 
(i.e., rodent being placed in water they cannot escape) than a test of depression-like 
behavior. Thus, our mice may actually be demonstrating dampened stress reactivity in the 
PNA conditions similar to those described by Ressler et al. (2015) in women with PCOS. 
If the DHT prenatal treatment does decrease stress reactivity, then we would expect to 
see an increase in mobility (i.e., less depression-like behavior) compared to prenatal 
saline controls which was observed in the current study. 
Applying this argument provides an explanation for the contradictory findings 
between the current study and previous work, and further suggests that future 
assessments of psychological and/or behavioral changes in animal models of PCOS 
might consider utilizing different tests to measure depression-like behavior. One example 
of an alternative test for depression-like behavior is the sucrose preference test. Snyder, 
Soumier, Brewer, Pickel, & Cameron (2012) used a stress paradigm, not related to a 
PCOS model, and examined depression-like behavior using the forced swim and sucrose 
preference test; finding changes in depression-like behavior on both tasks. The sucrose 
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preference test is based on anhedonia, or lack of enjoyment from activities, which is a 
common symptom of depression. In a similar vein, Kim, Yang, Kwon, Woo Lee, and 
Kim (2017) used an unpredictable shock stressor and found that the sucrose preference 
test showed changes in anhedonia-like behavior that were not visible in the forced swim 
test. Thus, sucrose preference tests may allow researchers to study other depression-like 
symptoms (i.e., anhedonia or lack of pleasure) in animal models and using a test with 
construct validity for depression-like behavior may provide a more accurate assessment 
of the effects of PCOS models. 
PNA model  
 In the current study, our PNA model resulted in a narrow change in anxiety-like 
behavior that was not in the anticipated direction and a change in depression-like 
behavior that was contrary to prior findings. The PNA model also resulted in increases in 
anogenital distance and qualitative differences in sexual maturity as measured by vaginal 
redness, indicating that physiological changes were associated with the prenatal treatment. 
Future studies might consider more thoroughly evaluating the redness and vaginal fusion 
present in PNA mice. Alternatively, another measure related to sexual maturity is the 
estrous cycle, which can provide biological information about the hormones present at 
different stages of the cycle (Caligioni, 2009). For example, Caldwell et al. (2014) 
reported that PNA mice completed fewer estrous cycles. Anogenital distance is another 
revealing measure used in PCOS models because female rodents treated with testosterone 
should show longer anogenital phenotypes (Wu et al., 2017) as observed in the current 
study. 
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As a model of PCOS, prenatal treatments have been well studied in regard to 
physiological phenotypes in animal models, while investigations of anxiety- and 
depression-like behavior are largely understudied. Thus, it may also be important to 
include estrous cycle information is order to ensure hormonal changes are not impacting 
behavior on tests like the EZM or forced swim test.  Meziane, Ouagazzal, Aubert, 
Wietrzych, and Krezel (2007) used a battery of behavioral tests to compare strain and 
estrous cycle differences on behavior and found their largest differences on a despair-like 
behavioral test similar to the forced swim test.  In particular, C57BL/6J mice showed 
increased immobility on the despair-like behavioral test while in the stage of metestrous.  
Thus, potential effects of estrous cycle stage on behavioral measures may be especially 
important to evaluate in a PCOS model, which is known to impact hormone regulation 
and estrous cycle. Measuring estrus cycle could also help to identify the acyclicity often 
found in models of PCOS. Ovarian measures (i.e., ovarian weight and presence of cysts) 
are also commonly reported as physiological properties of PCOS models (i.e., Caldwell 
et al., 2014; Walters et al., 2012) and future research could include ovarian measures to 
evaluate prenatal PNA models for both behavior and physiological changes. 
PNA and Stress 
 As mentioned previously, prenatal exposure to DHT as a model for PCOS 
resulted in narrow and contradicting differences in behavior on the EZM; as such, it is 
interesting to consider the interplay of the PNA and CORT treatments. Ressler et al. 
(2015) discussed how DHT treatment resulted in a dampened CORT response during 
novel environment exposure. That finding was not replicated in the current study, 
because if PNA were to dampen reactivity to CORT, then it would be expected that 
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CORT pellet implantation in DHT-treated animals would result in increased time spent in 
the open arms due to less fear or anxiety. These scenarios present the plausibility that the 
complex interaction between CORT and PNA treatment is more complex than a test such 
as the EZM can unmask. Moreover, an important aspect in understanding the interplay of 
PNA and CORT is to analyze CORT serum levels.  Performing this serum analysis might 
help in understanding the difference in CORT reactivity in models of PCOS. 
 Behavioral findings from our prenatal PCOS model support further study into 
behavioral differences using other anxiety- and depression-like tests.  It is likely that the 
depression experienced in women with PCOS arises from hormonal dysfunction and 
alterations to the HPA axis which have been found in some people with depression 
(Varghese & Brown, 2001). In particular, the dexamethasone suppression test (i.e., Carrol 
et al., 1982) show that a subset of individuals with depression respond abnormally to 
administration of the synthetic cortisol and do not decrease their own endogenous cortisol 
production. Importantly, depression resulting from dysfunctional neuroendocrine systems 
has not been validated in classical behavioral tests like the forced swim test which should 
be a consideration when selecting behavioral tests in PCOS rodent models.  
Genetic factors have been found that influence the connection between stress and 
mental illness. A longitudinal study by Capsi et al. (2003) found that some participants 
with depression also had a serotonin transporter allele variant that altered the functioning 
of serotonin, a neurotransmitter related to depression. In their study, life stress events 
were measured and correlated with the allele variant, and the authors concluded that the 
interaction of stress with this genetic polymorphism enhanced the development of mental 
illness (Capsi et al., 2003).  In a meta-analysis evaluating depression and stress, Karg, 
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Burmeister, Shedden, and Sen (2011) found strong connections between the same allele 
described by Capsi et al. (2003) and stress and depression. Thus, genetic variability 
among women with PCOS or between animal strains used in PCOS models may 
influence the appearance of anxiety- or depression-like behaviors. 
If the depression observed in women with PCOS results from an underlying 
physiological basis rather than from sociocultural stressors, then hormone alterations may 
underpin depression in these women and classic behavioral tests for depression-like 
behavior in mice may not be sensitive models for this type of depression. To note, the 
tests used in the current research do have predictive validity in pharmaceutical research 
but, as a result, may not have generalizability when applied to circumstances other than 
that associated with monoamine-altering antidepressants (Petit-Demouliere, Chenu, & 
Bourin, 2005). As mentioned previously, other tests such as the sucrose preference test 
could add complexity and accuracy to the depression-like behaviors measured in rodent 
models.  
Validating the Physiological Model 
This study is in agreement with previous reports that body weight does not 
increase in PNA mice either prior to weaning or during young adulthood (i.e., Caldwell et 
al., 2014; Roland et al., 2010; Walters et al., 2012), although these findings do contrast 
with a report from Caldwell et al. (2014) of increased weight gain in a postnatal model of 
PCOS. For example, in examining animals at 3, 4, and 5 months of age (i.e., later ages 
than measured in the current study), Roland and colleagues (2010) did not report weight 
differences in a prenatal PCOS model. One explanation for the lack of weight differences 
in prenatal PCOS models may be based on reabsorption that occurs in rodents to optimize 
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survival of offspring. Jafari et al. (2017) examined reabsorption rates in C57Bl/6J mice 
exposed to an auditory stress and found dams to have higher levels of reabsorption and 
fewer birthed pups. If the prenatal DHT treatment were a perceived stressor, either 
physiologically or environmentally, those mice of a lower fetal weight may have 
undergone reabsorption, with the remaining offspring displaying higher resiliency to 
environmental or physiological stressors. As we see a trend towards smaller DHT litters 
this could be an important consideration.  
CORT treatment decreased body weight in the current study.  Because stress 
responses involve the body diverting energy to the sympathetic system and away from 
functions like building body weight, it would be expected that subjects in the stress 
condition weighed less than controls (Divyashree & Yajurvedi, 2016) although a lack of 
body weight differences following CORT pellet implantation has been reported (Sturm et 
al., 2015). CORT serum level analysis will be undertaken on samples collected during the 
current study and are expected to confirm higher CORT levels in those mice implanted 
with CORT pellets as observed by Sturm and colleagues’ (2015). Future research should 
verify serum CORT levels from pellets. Understanding and measuring these specific 
changes are necessary for further validating the CORT treatment. 
Limitations 
 Several limitations to this study were identified upon completion. There were a 
restricted number of prenatal saline subjects due to small litter sizes in saline-treated 
dams. Due to multiple within subject ANOVA analyses, inherent type I error is probable 
(i.e., false-positive) and explains the marginal change in decreased anxiety-like behavior 
in PNA mice at minute 4 on the EZM.  This difference in anxiety-like behavior could be 
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produced by this false-positive result. Nonetheless, the ANOVA tests were used 
appropriately and the type I error or alpha inflation is a result of the test itself. Large 
differences in scores were also found in minute 4 of the elevated zero maze. Another 
limitation occurred due to difficulties in coding the videos from the forced swim test due 
to low room lighting, which were reduced because Huang, Zhou, and Zhang (2012) 
identified changes in anxiety-like behavior and performance on the Morris Water Maze in 
reaction to bright lighting conditions. Based upon these prior findings and in order to 
prevent overhead lights from altering behavior, the light in our testing room was 
decreased which, unfortunately, resulted in poor video quality for the forced swim test.  
Future research 
 Several suggestions regarding future research have already been made. To 
reiterate, for the EZM, future research should consider including coding exploratory 
behaviors for a potentially more robust measure of anxiety-like behavior. As for the 
forced swim test and depression-like behavior, it may be important to include other 
behavioral assays; for example, the sucrose preferences test. As well, the importance of 
measuring neuronal tissue in relation to behavioral changes would be an important 
physiological end point. The confirmation of vaginal redness as a measure of vaginal 
opening in PNA mice would also be important, as would measures of estrous cycle and 
ovarian morphology for validating the PNA model. Furthermore, estrous cycle measures 
may be important in enhancing our understanding of behavior variations on the EZM 
and/or forced swim test and could potentially allow us to unmask differences due to 
prenatal or postnatal treatments.  
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 Another important area of PCOS research, which remains unexplored, involves 
examining the impact of prenatal DHT treatment on male offspring behavior.  Only 
female offspring were used in the current study; however, there may be changes to PNA 
males as well. Male offspring from the treated dams were also run on behavioral testing 
and analysis will be done in the future. Elevated in utero testosterone was shown, in a 
study comparing women with and without PCOS, to increase androstenedione in male 
and female offspring (Daan, Koster, Steegers-Theunissen, Eijkemans, & Fauser, 2017).  
Moreover, offspring from women with PCOS showed that elevated levels of testosterone 
impacted androgen hormone levels in their offspring. A related study found that male rats 
exposed to prenatal testosterone showed increased hypertension features later in life 
(Chinnathambi, Balakrishnan, Yallampalli, & Sathishkumar, 2012).  Male offspring that 
have experienced an elevated testosterone environment in utero also demonstrate higher 
levels of testosterone in adulthood when compared to controls (as cited in Chinnathambi 
et al., 2012). Lastly, in a study using male sheep as a model of elevated in utero 
testosterone, altered responsiveness of hormones for gonadal development and regulation 
was found (i.e., gonadotropin-releasing hormone; Recabarren et al., 2012). These 
findings indicate that male reproductive systems show abnormalities following elevated 
prenatal testosterone, and, thus, it may be useful to explore behavioral changes in males 
exposed to our prenatal PCOS model. 
 Studies on carryover effects in behavioral testing have yielded mixed results 
across various tests and rodent models. Blokland et al. (2012) found that the forced swim 
test was more sensitive than the EZM to testing history in rats, which would indicate that 
the opposite order should have been employed in the current study. However, the forced 
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swim test was the only assay for which Blokland et al. controlled the ordering of testing, 
limiting the applicability of their findings. Future research may find differences if they 
staggered the order of EZM testing. Alternatively, testing order may not have impacted 
behavior in the current study; McIlwain et al., (2001) found that mice showed similar 
behavior in the open-field test regardless of testing history. Given that either our prenatal 
or postnatal manipulations may have altered animal sensitivity to the behavioral tests, it 
may be useful to investigate order of testing effects in future PCOS research.  
Conclusion  
 The prenatal model of PCOS used in the current research attempted to examine 
changes in anxiety- and depression-like behaviors. In addition to the standard prenatal 
model of PCOS, a stress condition was induced to more accurately model the human 
experience of PCOS. Behavioral tests were used to analyze differences due to the 
prenatal model of PCOS and the postnatal stress manipulation. Behavioral differences 
were found in both the EZM and forced swim test, with decreased anxiety-like behavior 
found in one of the five minutes of testing on the EZM and decreased depression-like 
behavior found in PNA as compared to prenatal saline mice. Differences were also found 
in physiological measures, including anogenital distance, body weight, and vaginal 
redness that are consistent with what was expected for our prenatal and postnatal 
treatments. Modeling PCOS in animal models is crucial to creating a better understanding 
of the etiology, biological mechanisms, and potential treatments for this syndrome. 
Women with PCOS suffer from various metabolic and reproductive difficulties, including 
increased risk of diabetes, obesity, infertility, and ovarian cysts. Not only do women with 
PCOS suffer from physical symptoms associated with the disorder but they also have an 
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increased risk for developing mental illness. Thus, it remains essential to research the 
connections between PCOS and mental health in order to create better treatments. 
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Appendix A 
Behavioral Assays Used for Depression- and Anxiety-like Behavior 
Elevated zero maze                                        Forced swim test 
 
 
 
 
